Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-036191
Filing Date
2021-07-08
Accepted
2021-07-08 16:30:13
Documents
1
Period of Report
2021-07-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1522
  Complete submission text file 0001213900-21-036191.txt   3083
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 MAMILLA AVENUE JERUSALEM L3 9414904
Business Address
Silberman David (Reporting) CIK: 0001867998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35813 | Film No.: 211080491